Kura Oncology, Inc. (KURA)
8.77
-0.06
(-0.68%)
USD |
NASDAQ |
May 01, 16:00
8.78
+0.01
(+0.11%)
After-Hours: 20:00
Kura Oncology Profit Margin (Quarterly) : -467.2% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 9.65% |
| ANI Pharmaceuticals, Inc. | 10.28% |
| Lexicon Pharmaceuticals, Inc. | -282.7% |
| Novavax, Inc. | 11.91% |
| Liquidia Corp. | 15.82% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -92.88% |
| Return on Assets | -36.15% |
| Return on Invested Capital | -87.33% |
| Gross Profit Margin (Quarterly) | 97.35% |
| Operating Margin (Quarterly) | -497.6% |
| Return on Net Operating Assets | -2.02K% |